Nicholas J. Hart
Nicholas J. Hart is the Chief Executive Officer of IBSA Pharma Inc., leading the company's U.S. commercial and strategic operations. He has more than 25 years of experience across the pharmaceutical industry, building and leading both large and small pharma organizations, public and private, with significant work in product launches, commercialization, business development, and licensing across therapy areas including women's health, endocrinology, oncology, urology, cardiovascular, diabetes, rheumatology, and CNS. Before joining IBSA in 2022, Nicholas was President and CEO of Ascend Therapeutics, President of the Specialty business at Lupin Pharmaceuticals, and Business Unit Head for Reproductive Endocrinology at Ferring Pharmaceuticals. Earlier in his career, he served as Senior Vice President of Marketing and Sales at URL Pharma, Vice President of Strategy and Development at Emisphere Technologies, and Therapeutic Area Leader for Women's Healthcare at Organon Pharmaceuticals. Nicholas received his undergraduate degree from the United States Military Academy at West Point and holds an M.B.A. from NYU Stern School of Business.